FIELD: medicine.
SUBSTANCE: for normalisation of thrombocyte susceptibility for aggregation stimulation for arterial hypertension (AH) patients under metabolic syndrome (MS) a complex therapy is performed for at least 8 weeks, including individual hypocaloric diet, rated physical exercise and introduction of 80 mg of valsartan each morning.
EFFECT: normalisation of thrombocyte susceptibility for aggregation stimulation agents due to reduction of high initial thrombocyte glycoproteid level for this group of patients.
1 ex, 2 tbl, 3 dwg
Authors
Dates
2009-01-27—Published
2007-05-28—Filed